Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT

Ines Valenta, Alessandra Quercioli, Gabriella Vincenti, René Nkoulou, Stephan Dewarrat, Olivier Rager, Habib Zaidi, Yann Seimbille, Francois MacH, Osman Ratib, Thomas H. Schindler

Research output: Contribution to journalArticle

Abstract

Background. The aim of this study was to determine whether epicardial structural disease may affect the manifestation of a longitudinal decrease in myocardial blood flow (MBF) or MBF difference during hyperemia in cardiovascular risk individuals, and its dependency on the flow increase. Methods and Results. In 54 cardiovascular risk individuals (at risk) and in 26 healthy controls, MBF was measured with 13N-ammonia and PET/CT in mL/g/min at rest and during dipyridamole stimulation. Computed tomography coronary angiography (CTA) was performed using a 64-slice CT of a PET/CT system. Absolute MBFs during dipyridamole stimulation were mildly lower in the mid-distal than in the mid-LV myocardium in controls (2.20 ± .51 vs 2.29 ± .51, P <.0001), while it was more pronounced in at risk with normal and abnormal CTA (1.56 ± .42 vs 1.91 ± .46 and 1.18 ± .34 vs 1.51 ± .40 mL/g/min, respectively, P <.0001), resulting in a longitudinal MBF difference that was highest in at risk with normal CTA, intermediate in at risk abnormal CTA, and lowest in controls (.35 ± .16 and .22 ± .09 vs .09 ± .04 mL/g/min, respectively, P <.0001). On multivariate analysis, log-CCS and mid-LV hyperemic MBF increase, indicative of microvascular function, were independent predictors of the observed longitudinal MBF difference (P ≤ .004 by ANOVA). Conclusions. Epicardial structural disease and microvascular function are important determinants of an abnormal longitudinal MBF difference as determined with PET/CT. (J Nucl Cardiol 2010;17:1023-33.)

Original languageEnglish (US)
Pages (from-to)1023-1033
Number of pages11
JournalJournal of Nuclear Cardiology
Volume17
Issue number6
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Coronary Angiography
Dipyridamole
Hyperemia
Ammonia
Myocardium
Analysis of Variance
Multivariate Analysis
Computed Tomography Angiography

Keywords

  • Coronary artery disease
  • Coronary circulation
  • Endothelial function
  • Myocardial blood flow
  • Positron emission tomography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. / Valenta, Ines; Quercioli, Alessandra; Vincenti, Gabriella; Nkoulou, René; Dewarrat, Stephan; Rager, Olivier; Zaidi, Habib; Seimbille, Yann; MacH, Francois; Ratib, Osman; Schindler, Thomas H.

In: Journal of Nuclear Cardiology, Vol. 17, No. 6, 12.2010, p. 1023-1033.

Research output: Contribution to journalArticle

Valenta, Ines ; Quercioli, Alessandra ; Vincenti, Gabriella ; Nkoulou, René ; Dewarrat, Stephan ; Rager, Olivier ; Zaidi, Habib ; Seimbille, Yann ; MacH, Francois ; Ratib, Osman ; Schindler, Thomas H. / Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. In: Journal of Nuclear Cardiology. 2010 ; Vol. 17, No. 6. pp. 1023-1033.
@article{9d4dea1e6bc9474786aad3062cae47c7,
title = "Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT",
abstract = "Background. The aim of this study was to determine whether epicardial structural disease may affect the manifestation of a longitudinal decrease in myocardial blood flow (MBF) or MBF difference during hyperemia in cardiovascular risk individuals, and its dependency on the flow increase. Methods and Results. In 54 cardiovascular risk individuals (at risk) and in 26 healthy controls, MBF was measured with 13N-ammonia and PET/CT in mL/g/min at rest and during dipyridamole stimulation. Computed tomography coronary angiography (CTA) was performed using a 64-slice CT of a PET/CT system. Absolute MBFs during dipyridamole stimulation were mildly lower in the mid-distal than in the mid-LV myocardium in controls (2.20 ± .51 vs 2.29 ± .51, P <.0001), while it was more pronounced in at risk with normal and abnormal CTA (1.56 ± .42 vs 1.91 ± .46 and 1.18 ± .34 vs 1.51 ± .40 mL/g/min, respectively, P <.0001), resulting in a longitudinal MBF difference that was highest in at risk with normal CTA, intermediate in at risk abnormal CTA, and lowest in controls (.35 ± .16 and .22 ± .09 vs .09 ± .04 mL/g/min, respectively, P <.0001). On multivariate analysis, log-CCS and mid-LV hyperemic MBF increase, indicative of microvascular function, were independent predictors of the observed longitudinal MBF difference (P ≤ .004 by ANOVA). Conclusions. Epicardial structural disease and microvascular function are important determinants of an abnormal longitudinal MBF difference as determined with PET/CT. (J Nucl Cardiol 2010;17:1023-33.)",
keywords = "Coronary artery disease, Coronary circulation, Endothelial function, Myocardial blood flow, Positron emission tomography",
author = "Ines Valenta and Alessandra Quercioli and Gabriella Vincenti and Ren{\'e} Nkoulou and Stephan Dewarrat and Olivier Rager and Habib Zaidi and Yann Seimbille and Francois MacH and Osman Ratib and Schindler, {Thomas H.}",
year = "2010",
month = "12",
doi = "10.1007/s12350-010-9272-9",
language = "English (US)",
volume = "17",
pages = "1023--1033",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT

AU - Valenta, Ines

AU - Quercioli, Alessandra

AU - Vincenti, Gabriella

AU - Nkoulou, René

AU - Dewarrat, Stephan

AU - Rager, Olivier

AU - Zaidi, Habib

AU - Seimbille, Yann

AU - MacH, Francois

AU - Ratib, Osman

AU - Schindler, Thomas H.

PY - 2010/12

Y1 - 2010/12

N2 - Background. The aim of this study was to determine whether epicardial structural disease may affect the manifestation of a longitudinal decrease in myocardial blood flow (MBF) or MBF difference during hyperemia in cardiovascular risk individuals, and its dependency on the flow increase. Methods and Results. In 54 cardiovascular risk individuals (at risk) and in 26 healthy controls, MBF was measured with 13N-ammonia and PET/CT in mL/g/min at rest and during dipyridamole stimulation. Computed tomography coronary angiography (CTA) was performed using a 64-slice CT of a PET/CT system. Absolute MBFs during dipyridamole stimulation were mildly lower in the mid-distal than in the mid-LV myocardium in controls (2.20 ± .51 vs 2.29 ± .51, P <.0001), while it was more pronounced in at risk with normal and abnormal CTA (1.56 ± .42 vs 1.91 ± .46 and 1.18 ± .34 vs 1.51 ± .40 mL/g/min, respectively, P <.0001), resulting in a longitudinal MBF difference that was highest in at risk with normal CTA, intermediate in at risk abnormal CTA, and lowest in controls (.35 ± .16 and .22 ± .09 vs .09 ± .04 mL/g/min, respectively, P <.0001). On multivariate analysis, log-CCS and mid-LV hyperemic MBF increase, indicative of microvascular function, were independent predictors of the observed longitudinal MBF difference (P ≤ .004 by ANOVA). Conclusions. Epicardial structural disease and microvascular function are important determinants of an abnormal longitudinal MBF difference as determined with PET/CT. (J Nucl Cardiol 2010;17:1023-33.)

AB - Background. The aim of this study was to determine whether epicardial structural disease may affect the manifestation of a longitudinal decrease in myocardial blood flow (MBF) or MBF difference during hyperemia in cardiovascular risk individuals, and its dependency on the flow increase. Methods and Results. In 54 cardiovascular risk individuals (at risk) and in 26 healthy controls, MBF was measured with 13N-ammonia and PET/CT in mL/g/min at rest and during dipyridamole stimulation. Computed tomography coronary angiography (CTA) was performed using a 64-slice CT of a PET/CT system. Absolute MBFs during dipyridamole stimulation were mildly lower in the mid-distal than in the mid-LV myocardium in controls (2.20 ± .51 vs 2.29 ± .51, P <.0001), while it was more pronounced in at risk with normal and abnormal CTA (1.56 ± .42 vs 1.91 ± .46 and 1.18 ± .34 vs 1.51 ± .40 mL/g/min, respectively, P <.0001), resulting in a longitudinal MBF difference that was highest in at risk with normal CTA, intermediate in at risk abnormal CTA, and lowest in controls (.35 ± .16 and .22 ± .09 vs .09 ± .04 mL/g/min, respectively, P <.0001). On multivariate analysis, log-CCS and mid-LV hyperemic MBF increase, indicative of microvascular function, were independent predictors of the observed longitudinal MBF difference (P ≤ .004 by ANOVA). Conclusions. Epicardial structural disease and microvascular function are important determinants of an abnormal longitudinal MBF difference as determined with PET/CT. (J Nucl Cardiol 2010;17:1023-33.)

KW - Coronary artery disease

KW - Coronary circulation

KW - Endothelial function

KW - Myocardial blood flow

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=78651266821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651266821&partnerID=8YFLogxK

U2 - 10.1007/s12350-010-9272-9

DO - 10.1007/s12350-010-9272-9

M3 - Article

C2 - 20658271

AN - SCOPUS:78651266821

VL - 17

SP - 1023

EP - 1033

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

IS - 6

ER -